歸創通橋-B(02190.HK):戰略投資微亞醫療以夯實公司在血管介入領域的領先地位
格隆匯1月17日丨歸創通橋-B(02190.HK)發佈公吿,為推動血管介入治療的標準化、精準化、智能化發展,完善公司對泛血管介入治療解決方案的佈局,公司決定作為戰略投資者投資微亞醫療科技(蘇州)有限公司(一家位於中國境內的創新醫療器械企業及公司的獨立第三方,並已於近日與微亞醫療簽署股權增資協議)。
此外,歸創通橋與微亞醫療已簽署戰略合作協議。根據戰略合作協議,公司將運用自有資源及專業,助力微亞醫療研發進程,加速商業化進程,共同推進血管介入機器人在臨牀應用的落地。同時,公司在特定區域將優先獲得微亞醫療所開發產品的獨家代理銷售權利,進一步加強公司向醫生、患者及醫院供應的產品佈局。
微亞醫療致力於開發應用於冠脈、神經、外周血管的介入手術機器人全面解決方案。依託公司深厚的技術積累與臨牀經驗,其全新獨創的遞送技術將提升血管介入手術效率、精準度與穩定性,全面滿足醫生介入手術的需求。產品實用性已受到國內多位頂級專家的認可。
董事會相信,此次對微亞醫療的戰略投資將夯實公司在血管介入領域的領先地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.